Lantern Pharma reported total assets of $8.60M and total liabilities of $11.82M for the quarter ended Jun 2026, down 50.6% year over year. This balance sheet covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables - AccuredAcc. Int. Receivables | 0.07M | 0.18M | 0.23M | 0.34M | 0.30M | 0.59M | 0.86M | 0.10M | 0.03M | 0.03M | 0.03M | |||||||||||||||||
| Assets | ||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 54.67M | 51.52M | 46.65M | 43.36M | 39.26M | 37.20M | 32.48M | 28.42M | 25.57M | 21.94M | 18.36M | 12.98M | 8.10M | 7.51M | 6.38M | 6.06M | 8.39M | 4.42M | 4.92M | 6.66M | ||||||||
| Receivables - OtherOther Receivables | ||||||||||||||||||||||||||||
| Prepaid Assets | 2.50M | 1.99M | 2.45M | 3.51M | 3.65M | 2.99M | 3.09M | 2.55M | 2.50M | 2.04M | 1.11M | 2.03M | 1.87M | 1.24M | 1.10M | 1.30M | 1.10M | 0.68M | 0.73M | 1.10M | ||||||||
| Current Assets | 76.34M | 72.72M | 67.66M | 65.66M | 62.02M | 58.72M | 55.17M | 51.04M | 47.43M | 43.34M | 39.47M | 35.29M | 29.92M | 25.25M | 20.82M | 17.20M | 13.46M | 10.80M | 7.06M | 8.46M | ||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.03M | 0.03M | 0.03M | 0.04M | 0.04M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.04M | 0.04M | 0.04M | 0.03M | 0.03M | 0.02M | ||||||||
| Long-Term Deferred Tax | 5.77M | |||||||||||||||||||||||||||
| Other Non-Current Assets | 1.00M | 1.00M | 0.54M | 0.54M | 0.54M | 0.54M | 0.54M | 0.54M | 0.03M | 0.03M | 0.03M | 0.03M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.09M | 0.05M | 0.05M | ||||||||
| Non-Current Assets | 1.27M | 1.23M | 0.74M | 0.72M | 0.14M | 0.11M | 0.34M | 0.38M | 0.35M | 0.31M | 0.26M | 0.30M | 0.37M | 0.32M | 0.27M | 0.22M | 0.17M | 0.23M | 0.17M | 0.14M | ||||||||
| Assets | 77.61M | 73.95M | 68.40M | 66.38M | 62.16M | 58.84M | 55.51M | 51.43M | 47.77M | 43.65M | 39.73M | 35.59M | 30.29M | 25.57M | 21.10M | 17.42M | 13.63M | 11.04M | 7.22M | 8.60M | ||||||||
| Liabilities | ||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||
| Accounts Payables | 1.64M | 2.17M | 2.92M | 5.17M | 3.05M | 2.75M | 2.67M | 2.85M | 2.09M | 2.51M | 3.78M | 4.44M | 3.40M | 4.14M | 4.12M | 4.75M | 3.95M | 4.42M | 3.72M | 4.28M | ||||||||
| Payables | 1.64M | 2.17M | 2.92M | 5.17M | 3.05M | 2.75M | 2.67M | 2.85M | 2.09M | 2.51M | 3.78M | 4.44M | 3.40M | 4.14M | 4.12M | 4.75M | 3.95M | 4.42M | 3.72M | 4.28M | ||||||||
| Accumulated Expenses | 0.91M | |||||||||||||||||||||||||||
| Current Leases | 0.15M | 0.15M | 0.16M | 0.13M | 0.09M | 0.05M | 0.12M | 0.16M | 0.17M | 0.17M | 0.18M | 0.16M | 0.20M | 0.19M | 0.06M | 0.13M | 0.09M | 0.08M | 0.06M | 0.04M | ||||||||
| Total Current Liabilities | 1.79M | 2.33M | 3.07M | 5.30M | 3.14M | 2.80M | 2.79M | 3.02M | 2.25M | 2.68M | 3.95M | 4.60M | 3.60M | 4.33M | 4.29M | 4.88M | 4.04M | 4.50M | 3.78M | 4.32M | ||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||
| Non-Current Debt | ||||||||||||||||||||||||||||
| Operating Leases | 0.24M | 0.20M | 0.17M | 0.13M | 0.09M | 0.05M | 0.14M | 0.15M | 0.11M | 0.06M | 0.19M | 0.22M | 0.29M | 0.05M | 0.06M | 0.01M | 0.08M | 0.06M | ||||||||||
| Non-Current Deferred Tax Liability | 0.01M | |||||||||||||||||||||||||||
| Other Non-Current Liabilities | 7.50M | |||||||||||||||||||||||||||
| Total Non-Current Liabilities | 4.32M | |||||||||||||||||||||||||||
| Total Liabilities | 1.88M | 2.38M | 3.09M | 5.30M | 3.14M | 2.80M | 2.93M | 3.17M | 2.36M | 2.74M | 3.97M | 4.66M | 3.70M | 4.38M | 4.32M | 4.90M | 4.04M | 4.50M | 3.78M | 11.82M | ||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||
| Total Debt | ||||||||||||||||||||||||||||
| Common Equity | 75.73M | 71.57M | 65.32M | 61.08M | 59.03M | 56.04M | 52.58M | 48.26M | 45.41M | 40.91M | 35.77M | 30.93M | 26.60M | 21.19M | 16.78M | 12.52M | 9.59M | 6.53M | 3.45M | -3.22M | ||||||||
| Liabilities and Shareholders Equity | 77.61M | 73.95M | 68.40M | 66.38M | 62.16M | 58.84M | 55.51M | 51.43M | 47.77M | 43.65M | 39.73M | 35.59M | 30.29M | 25.57M | 21.10M | 17.42M | 13.63M | 11.04M | 7.22M | 8.60M | ||||||||
| Retained Earnings | 97.31M | 96.69M | 94.77M | 95.06M | 95.36M | 95.69M | 96.02M | 96.42M | 96.61M | 96.26M | 96.45M | 96.58M | 96.77M | 97.06M | 97.21M | 97.37M | 98.62M | 99.65M | 99.95M | -103.55M | ||||||||
| Preferred Shares | ||||||||||||||||||||||||||||
| Treasury Shares | 0.35M |